Publications by authors named "Justin Garber"

Claim this Profile
R
Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry.
Enrique Gomez-Figueroa, Patricia Orozco-Puga, Cynthia Patricia Corona-Vázquez, Carlos Moreno-Bernardino, Graciela Elizabeth De la Mora-Landín, Justin Garber

Ther Adv Neurol Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMBAT-MS (group-based cognitive remediation and behavioural approaches to intervention in multiple sclerosis).
Keri Diamond, Robert Ruane, Caitlin Dawes, Sally Byrne, Marinda Taha, Justin Garber

Mult Scler Relat Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data.
Ashkan Pirmani, Edward De Brouwer, Ádám Arany, Martijn Oldenhof, Antoine Passemiers, Justin Garber

NPJ Digit Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depicting multiple sclerosis disease course using lesion parenchymal fraction: a quantified expression of the topographical model of multiple sclerosis.
Stephen Krieger, Thibo Billiet, Nuno Pedrosa de Barros, Thanh Vân Phan, Wim Van Hecke, Justin Garber

Brain Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.
Jannis Müller, Sifat Sharmin, Johannes Lorscheider, Serkan Ozakbas, Rana Karabudak, Justin Garber

JAMA Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
Cathérine Dekeyser, Matthias Hautekeete, Melissa Cambron, Vincent Van Pesch, Francesco Patti, Justin Garber

J Neurol Neurosurg Psychiatry· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Sifat Sharmin, Izanne Roos, Steve Simpson-Yap, Charles Malpas, Marina M Sánchez, Justin Garber

Brain· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation.
Chao Zhu, Tomas Kalincik, Dana Horakova, Zhen Zhou, Katherine Buzzard, Justin Garber

JAMA Neurol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Tomas Kalincik, Sifat Sharmin, Izanne Roos, Mark S Freedman, Harold Atkins, Justin Garber

JAMA Neurol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Cyrus Daruwalla, Vahid Shaygannejad, Serkan Ozakbas, Eva Kubala Havrdova, Dana Horakova, Justin Garber

Mult Scler· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI biomarkers of disease progression in multiple sclerosis: old dog, new tricks?
Yael Barnett, Justin Y Garber, Michael H Barnett

Quant Imaging Med Surg· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The electrophysiological assessment of visual function in Multiple Sclerosis.
Joshua L Barton, Justin Y Garber, Alexander Klistorner, Michael H Barnett

Clin Neurophysiol Pract· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic sequelae of primary HIV infection.
Bruce James Brew, Justin Y Garber

Handb Clin Neurol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
We should focus more on finding therapeutic targets for the non-inflammatory damage in MS - Yes.
Justin Y Garber, Michael H Barnett

Mult Scler· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis